Abstract:Target-specific drug release is indispensable to improve chemotherapeutic efficacy as it enhances drug uptake and penetration into tumors. Sono-responsive drug-loaded nano-/micro-particles are a promising solution for achieving target specificity by exposing them to ultrasound near tumors. However, the complicated synthetic processes and limited ultrasound (US) exposure conditions, such as limited control of ultrasound focal depth and acoustic power, prevent the practical application of this approach in clinical practice. Here, we propose a convex acoustic lens-attached US (CALUS) as a simple, economic, and efficient alternative of focused US for drug delivery system (DDS) application. The CALUS was characterized both numerically and experimentally using a hydrophone. In vitro, microbubbles (MBs) inside microfluidic channels were destroyed using the CALUS with various acoustic parameters (acoustic pressure [P], pulse repetition frequency [PRF], and duty cycle) and flow velocity. In vivo, tumor inhibition was evaluated using melanoma-bearing mice by characterizing tumor growth rate, animal weight, and intratumoral drug concentration with/without CALUS DDS. US beams were measured to be efficiently converged by CALUS, which was consistent with our simulation results. The acoustic parameters were optimized through the CALUS-induced MB destruction test (P = 2.34 MPa, PRF = 100 kHz, and duty cycle = 9%); this optimal parameter combination successfully induced MB destruction inside the microfluidic channel with an average flow velocity of up to 9.6 cm/s. The CALUS also enhanced the therapeutic effects of an antitumor drug (doxorubicin) in vivo in a murine melanoma model. The combination of the doxorubicin and the CALUS inhibited tumor growth by ∼ 55% more than doxorubicin alone, clearly indicating synergistic antitumor efficacy. Our tumor growth inhibition performance was better than other methods based on drug carriers, even without a time-consuming and complicated chemical synthesis process. This result suggests that our novel, simple, economic, and efficient target-specific DDS may offer a transition from preclinical research to clinical trials and a potential treatment approach for patient-centered healthcare.

Spatiotemporal Drug Delivery Using Laser-Generated-focused Ultrasound System

Ultrasound-actuated drug delivery with acoustic percolation switches

Experimental and simulation studies on focused ultrasound triggered drug delivery

Controlled Drug Release from Ultrasound-Visualized Elastic Eccentric Microcapsules Using Different Resonant Modes

A Fluorous Biphase Drug Delivery System Triggered by Low Frequency Ultrasound: Controlled Release from Perfluorous Discoidal Porous Silicon Particles.

Ultrasonic Generation of Pulsatile and Sequential Therapeutic Delivery Profiles from Calcium-Crosslinked Alginate Hydrogels

Low Frequency Ultrasound Triggering Drug Release from Improved PLGA Microcapsules in Vitro

Ultrasound triggered, image guided, local drug delivery

Novel Class of Ultrasound-Triggerable Drug Delivery Systems for the Improved Treatment of Tumors

Establishment of ultrasound-responsive SonoBacteriaBot for targeted drug delivery and controlled release

Ultrasound-Induced Drug Release from Stimuli-Responsive Hydrogels

Ultrasound-triggered disruption and self-healing of reversibly cross-linked hydrogels for drug delivery and enhanced chemotherapy

Ultrafast Laser-Ablated Bioinspired Hydrogel-Based Porous Gating System for Sustained Drug Release.

A Disposable Microfluidic Device for Controlled Drug Release from Thermal-Sensitive Liposomes by High Intensity Focused Ultrasound

A novel convex acoustic lens-attached ultrasound drug delivery system and its testing in a murine melanoma subcutaneous model

Targeted drug release from stable and safe ultrasound-sensitive nanocarriers

Ultrasound-Induced In Situ Dopamine Polymerization and Deep Mucosal Penetration for Intraluminal Drug Administration

Ultrasound-Responsive Liposomes for Targeted Drug Delivery Combined with Focused Ultrasound

Ultrasound Triggered Local Sequential Reactive Oxygen Species and Nitric Oxide Release for Enhanced Cerasomal Drug Delivery

Biointerfacing Polymeric Microcapsules for in Vivo Near-Infrared Light-Triggered Drug Release